| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Medical Clinic III, University of Dresden, Dresden, Germany; and
Max-Delbruck-Center for Molecular Medicine, Berlin-Buch, Germany
1Correspondence: Medical Clinic III, University of Dresden, Fetscherstr. 74, Dresden 01307, Germany. E-mail: Valeria.Zepter{at}uniklinikum-dresden.de
The causal relationship between obesity and heart failure is broadly acknowledged; however, the pathophysiological mechanisms involved remain unclear. In this study we investigated whether human adipocytes secrete cardioactive substances that may affect cardiomyocyte contractility. We cultivated adipocytes obtained from human white adipose tissue and incubated isolated rat adult cardiomyocytes with adipocyte-conditioned or control medium. This is the first report to demonstrate that human adipocytes exhibit cardiodepressant activity with a direct and acute effect on cardiomyocyte contraction. This adipocyte-derived negative inotropic activity directly depresses shortening amplitude as well as intracellular systolic peak Ca2+ in cardiomyocytes within a few minutes. The adipocyte-derived cardiodepressant activity was dose-dependent and was completely blunted by heating or by trypsin digestion. Filtration of adipocyte-conditioned medium based on molecular mass characterized the cardiodepressant activity at between 10 and 30 kDa. In summary, adipose tissue exerts highly potent activity with an acute depressant effect directly on cardiomyocytes, which may well contribute to increased heart failure risk in overweight patients—Lamounier-Zepter, V., Ehrhart-Bornstein, M., Karczewski, P., Haase, H., Bornstein, S. R., Morano, I. Human adipocytes attenuate cardiomyocyte contraction: characterization of an adipocyte-derived negative inotropic activity.
Key Words: cardiodepressant activity • calcium transient • obesity • heart failure
This article has been cited by other articles:
|
|
 |
|
  V. Lamounier-Zepter, C. Look, J. Alvarez, T. Christ, U. Ravens, W.-H. Schunck, M. Ehrhart-Bornstein, S. R. Bornstein, and I. Morano Adipocyte Fatty Acid-Binding Protein Suppresses Cardiomyocyte Contraction: A New Link Between Obesity and Heart Disease Circ. Res., August 14, 2009; 105(4): 326 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Denk, J. Albers, N. Kayhan, D. Ister, A. Bonz, C. Werner, T. Munzel, and C.-F. Vahl Evidence for a negative inotropic effect of obesity in human myocardium? Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 300 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Roberts, A. L. Clark, and K. K. Witte Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease -- do we need to screen our patients? Diabetes and Vascular Disease Research, July 1, 2009; 6(3): 153 - 163. [Abstract] [PDF]
|
|
|
|
 |
|
 V. Vu, W. Kim, X. Fang, Y.-T. Liu, A. Xu, and G. Sweeney Coculture with Primary Visceral Rat Adipocytes from Control But Not Streptozotocin-Induced Diabetic Animals Increases Glucose Uptake in Rat Skeletal Muscle Cells: Role of Adiponectin Endocrinology, September 1, 2007; 148(9): 4411 - 4419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin Endocr. Rev., August 1, 2007; 28(5): 463 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Nisoli, E. Clementi, M. O. Carruba, and S. Moncada Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome? Circ. Res., March 30, 2007; 100(6): 795 - 806. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
